Literature DB >> 22515484

Vascular calcification in South African dialysis patients: ethnic variation, prevalence, detection and haemodynamic correlates.

Robert Freercks1, Charles Swanepoel, Henri Carrara, Sulaiman Moosa, Anthony Lachman, Brian Rayner.   

Abstract

AIM: Studies from the US have shown little effect of ethnicity on vascular calcification in dialysis patients. This has not been examined in the multi-ethnic population of South Africa where genetic and environmental differences may exist. We assessed the extent and severity of vascular calcification in South African dialysis patients according to race and known risk factors. We further evaluated the association of abdominal aorta calcification with coronary artery calcification.
METHOD: Seventy-five CKD-5D patients and 20 healthy controls were enrolled consecutively. All subjects underwent chest computed tomography for coronary calcium score and abdominal X-ray for abdominal aorta calcium score. Ambulatory blood pressure monitoring was generated via radial artery applanation tonometry.
RESULTS: Coronary calcification was present in 38.6% of patients and was associated with age and prior cardiovascular disease on multivariate analyses. The median coronary calcium score in black patients was 0 (IQR 0) and 66 in non-Blacks (IQR 383, P < 0.001); controls had a coronary calcium score of 0 (IQR 0). Black race remained a significant negative predictor for coronary calcification after adjustment, prevalence ratio = 0.14 and 95% confidence interval (CI): 0.0-0.53. Vascular calcification was not associated with any ambulatory blood pressure parameter. Using receiver operator characteristic curves, an abdominal aorta calcification score of ≥1 showed an area under the curve of 0.83 to predict a coronary calcium score ≥ 10.
CONCLUSION: Black race appears to protect from vascular calcification in South African CKD-5D patients and this warrants further study regarding the underlying mechanism. The abdominal X-ray is a useful screening tool for coronary calcification.
© 2012 The Authors. Nephrology © 2012 Asian Pacific Society of Nephrology.

Entities:  

Mesh:

Year:  2012        PMID: 22515484     DOI: 10.1111/j.1440-1797.2012.01612.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  6 in total

1.  Prevalence of abdominal artery calcification in dialysis patients with end-stage renal disease: a systematic review and meta-analysis.

Authors:  Zhihui Yao; Congxia Wang; Qiaona Zhang; Shan Ma; Baosong Gui; Chaoyang Duan
Journal:  Int Urol Nephrol       Date:  2017-09-21       Impact factor: 2.370

2.  Racial Variations in the Markers of Mineral Bone Disorders in CKD Patients in South Africa.

Authors:  Bala Waziri; Raquel Duarte; Caroline Dickens; Therese Dix Peek; Jaya George; Vakhtang Rekhviashvili; Graham Paget; Saraladevi Naicker
Journal:  Kidney Int Rep       Date:  2017-12-12

3.  Coronary artery calcium, HIV and inflammation in Uganda compared with the USA.

Authors:  Ben Alencherry; Geoffrey Erem; Grace Mirembe; Isaac Ssinabulya; Chun-Ho Yun; Chung-Lieh Hung; Mark J Siedner; Marcio Bittencourt; Cissy Kityo; Grace A McComsey; Chris T Longenecker
Journal:  Open Heart       Date:  2019-05-22

4.  Cardiovascular Risk Factor Profiles and Disease in Black Compared to Other Africans with Chronic Kidney Disease.

Authors:  Hon-Chun Hsu; Chanel Robinson; Angela J Woodiwiss; Gavin R Norton; Patrick H Dessein
Journal:  Int J Nephrol       Date:  2021-02-19

5.  Vascular calcification is not associated with increased ambulatory central aortic systolic pressure in prevalent dialysis patients.

Authors:  Robert J Freercks; Charles R Swanepool; Kristy L Turest-Swartz; Henri R O Carrara; Sulaiman El Moosa; Anthony S Lachman; Brian L Rayner
Journal:  Cardiovasc J Afr       Date:  2014 Jan-Feb       Impact factor: 1.167

6.  Atherosclerotic vascular disease is more prevalent among black ESKD patients on long-term CAPD in South Africa.

Authors:  S O Oguntola; M O Hassan; R Duarte; A Vachiat; P Manga; S Naicker
Journal:  BMC Nephrol       Date:  2019-10-30       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.